BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16913546)

  • 21. Health technology assessment of surgical therapies for benign gynaecological disease.
    Owusu-Ansah R; Gatongi D; Chien PF
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):841-79. PubMed ID: 17145485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
    Goldberg J; Bussard A; McNeil J; Diamond J
    Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
    Gallinat A
    Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative costs of gynecologic endoscopy vs traditional surgery for treatment of abnormal uterine bleeding.
    Hidlebaugh DA
    Am J Manag Care; 2001 Sep; 7 Spec No():SP31-7. PubMed ID: 11599673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Burch colposuspension ever cost-effective compared with tension-free vaginal tape for stress incontinence?
    Wu JM; Visco AG; Weidner AC; Myers ER
    Am J Obstet Gynecol; 2007 Jul; 197(1):62.e1-5. PubMed ID: 17618760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing drug-resistant essential menorrhagia without hysterectomy.
    Hurskainen R
    Best Pract Res Clin Obstet Gynaecol; 2006 Oct; 20(5):681-94. PubMed ID: 16731045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of early treatment for retinopathy of prematurity.
    Kamholz KL; Cole CH; Gray JE; Zupancic JA
    Pediatrics; 2009 Jan; 123(1):262-9. PubMed ID: 19117891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia.
    You JH; Sahota DS; MoYuen P
    Hum Reprod; 2006 Jul; 21(7):1878-83. PubMed ID: 16585125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda.
    Okello D; Floyd K; Adatu F; Odeke R; Gargioni G
    Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S72-9. PubMed ID: 12971657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thermal balloon endometrial ablation for dysfunctional uterine bleeding: technical aspects and results. A prospective cohort study of 152 cases].
    Kdous M; Jacob D; Gervaise A; Risk E; Sauvanet E
    Tunis Med; 2008 May; 86(5):473-8. PubMed ID: 19469303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost of microwave endometrial ablation under different anaesthetic and clinical settings.
    Seymour J; Wallage S; Graham W; Parkin D; Cooper K
    BJOG; 2003 Oct; 110(10):922-6. PubMed ID: 14550362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial ablation with NovaSure GEA, a pilot study.
    Busund B; Erno LE; Grønmark A; Istre O
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of long-term safety and effectiveness of a third-generation thermal uterine balloon therapy system for heavy menstrual bleeding.
    Cash C; Garza-Leal J; Donovan A; Guidry C; Romanowski C; Patel B
    J Minim Invasive Gynecol; 2012; 19(4):469-76. PubMed ID: 22748952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling.
    Garside R; Stein K; Wyatt K; Round A; Price A
    Health Technol Assess; 2004 Feb; 8(3):iii, 1-155. PubMed ID: 14754561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Brown PM; Farquhar CM; Lethaby A; Sadler LC; Johnson NP
    BJOG; 2006 Jul; 113(7):797-803. PubMed ID: 16827763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.